Non-routine tracers for PET imaging of high-grade glioma

Research output: Contribution to journalReview articlepeer-review


Thorough imaging is crucial for diagnosis and treatment of high-grade gliomas (HGG), lethal brain tumours with median survival ranging 1-5 years after diagnosis. Positron-emission tomography (PET) is acquiring importance in imaging of HGG since it has the formidable advantage of providing information on tumour metabolism that may be critical for correct diagnosis and treatment planning. Recently employed PET tracers designed for the non-routine investigation of specific aspects of HGG metabolism, including hypoxia, neoangiogenesis, expression of integrins and stem cell markers, are reviewed herein. A thorough choice from among these non-routine tracers may provide important metabolic information complementing those obtained with more common PET analyses, for the sake of diagnostic, prognostic, treatment planning or research purposes.

Original languageEnglish
Pages (from-to)3253-3260
Number of pages8
JournalAnticancer Research
Issue number7
Publication statusPublished - 2016


  • Diagnostic techniques and procedures
  • Functional neuroimaging
  • Glioblastoma
  • Glioma
  • Radionuclide imaging
  • Review

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Non-routine tracers for PET imaging of high-grade glioma'. Together they form a unique fingerprint.

Cite this